Ebola virus: first person vaccinated in UK trial of new jab
A volunteer in the UK received the first dose of a new Ebola vaccine on Friday. This vaccine targets the Bundibugyo strain of Ebola, which is responsible for a deadly outbreak in the Democratic Republic of Congo (DRC) and Uganda.

Briefing Summary
AI-generatedA volunteer in the UK received the first dose of a new Ebola vaccine on Friday. This vaccine targets the Bundibugyo strain of Ebola, which is responsible for a deadly outbreak in the Democratic Republic of Congo (DRC) and Uganda. The World Health Organization reports that over 1,000 people have died from this outbreak since it began in May. Oxford University announced the vaccination as part of a clinical trial. Researchers and health organizations have been working rapidly to develop a vaccine or treatment for this specific, less common strain of Ebola and bring it to human testing.
Article analysis
Model · rule-basedKey claims
4 extractedResearchers and health organizations are working to develop a vaccine or treatment for this Ebola strain.
Over 1,000 people have died in the DRC and Uganda since the outbreak began in May.
The Bundibugyo strain of Ebola is driving a deadly outbreak in the Democratic Republic of Congo (DRC).
A volunteer received the first dose of a new Ebola vaccine targeting the Bundibugyo strain in a UK trial.